Antibody-drug conjugates in prostate cancer: current landscape and future directions
Antibody-drug conjugates (ADCs) have emerged as a promising therapeutic option, combining the specificity of monoclonal antibodies with the potency of cytotoxic payloads. While initially developed for hematologic and select solid malignancies, advances in antigen discovery, linker chemistry, and pay...
में बचाया:
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publishing
2026-03-01
|
| श्रृंखला: | Therapeutic Advances in Medical Oncology |
| ऑनलाइन पहुंच: | https://doi.org/10.1177/17588359261424672 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|